Cetuximab, Docetaxel, and Cisplatin vs Platinum, Fluorouracil, and Cetuximab as First-Line Treatment in Recurrent or Metastatic HNSCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology